Sort   by:  
 Page size 
UnknownEfficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trial.
Not available
S-EPMC11420323 | biostudies-literature
UnknownQuercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
Not available
S-EPMC4488803 | biostudies-literature
Sort   by:  
 Page size